Covid-19 : clinical aspects and management
Copyright © 2020 Elsevier Masson SAS. All rights reserved..
Asymptomatic infections are not rare and most patients complain with fever and respiratory signs. Clinical signs are polymorphic and aspecific. Chest CT scan is commonly used as a diagnostic and triage tool in patients admitted to hospitalization. The 2 main complications are respiratory distress related to worsening pneumonia with an associated cytokine storm occurring mostly 7 to 10 days after disease onset, and thromboembolic disease. The fatality rate is around 2%. In-hospital management includes oxygen supply when needed and prevention of thromboembolic disease. Associated bacterial infections seem to be rare. Remdesivir might reduce the time to recovery in hospitalized patients needing an oxygen supply. Dexamethasone might reduce the fatality rate in patients requiring mechanical ventilation. The development of many candidate vaccines gives hope to fight the pandemic.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:2020 |
---|---|
Enthalten in: |
Revue francophone des laboratoires : RFL - 2020(2020), 526 vom: 06. Nov., Seite 40-47 |
Sprache: |
Französisch |
---|
Weiterer Titel: |
Covid-19 : aspects cliniques et principaux éléments de prise en charge |
---|
Beteiligte Personen: |
Desvaux, Édouard [VerfasserIn] |
---|
Links: |
---|
Themen: |
Chest CT-scan |
---|
Anmerkungen: |
Date Revised 12.11.2023 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1016/S1773-035X(20)30312-9 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM317308769 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM317308769 | ||
003 | DE-627 | ||
005 | 20231225163009.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||fre c | ||
024 | 7 | |a 10.1016/S1773-035X(20)30312-9 |2 doi | |
028 | 5 | 2 | |a pubmed24n1057.xml |
035 | |a (DE-627)NLM317308769 | ||
035 | |a (NLM)33163103 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a fre | ||
100 | 1 | |a Desvaux, Édouard |e verfasserin |4 aut | |
245 | 1 | 0 | |a Covid-19 |b clinical aspects and management |
246 | 3 | 3 | |a Covid-19 : aspects cliniques et principaux éléments de prise en charge |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 12.11.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Copyright © 2020 Elsevier Masson SAS. All rights reserved. | ||
520 | |a Asymptomatic infections are not rare and most patients complain with fever and respiratory signs. Clinical signs are polymorphic and aspecific. Chest CT scan is commonly used as a diagnostic and triage tool in patients admitted to hospitalization. The 2 main complications are respiratory distress related to worsening pneumonia with an associated cytokine storm occurring mostly 7 to 10 days after disease onset, and thromboembolic disease. The fatality rate is around 2%. In-hospital management includes oxygen supply when needed and prevention of thromboembolic disease. Associated bacterial infections seem to be rare. Remdesivir might reduce the time to recovery in hospitalized patients needing an oxygen supply. Dexamethasone might reduce the fatality rate in patients requiring mechanical ventilation. The development of many candidate vaccines gives hope to fight the pandemic | ||
650 | 4 | |a English Abstract | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Covid-19 | |
650 | 4 | |a chest CT-scan | |
650 | 4 | |a clinical signs | |
650 | 4 | |a management | |
650 | 4 | |a vaccine | |
700 | 1 | |a Faucher, Jean-François |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Revue francophone des laboratoires : RFL |d 2006 |g 2020(2020), 526 vom: 06. Nov., Seite 40-47 |w (DE-627)NLM308737768 |x 1773-035X |7 nnns |
773 | 1 | 8 | |g volume:2020 |g year:2020 |g number:526 |g day:06 |g month:11 |g pages:40-47 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/S1773-035X(20)30312-9 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 2020 |j 2020 |e 526 |b 06 |c 11 |h 40-47 |